| Safety and impact of low-dose methotrexate on endothelial function and inflammation in individuals with treated human immunodeficiency virus: AIDS Clinical Trials Group Study A5314 PY Hsue, HJ Ribaudo, SG Deeks, T Bell, PM Ridker, C Fichtenbaum, ... Clinical Infectious Diseases 68 (11), 1877-1886, 2019 | 49 | 2019 |
| MicroRNA circulating in the early aftermath of motor vehicle collision predict persistent pain development and suggest a role for microRNA in sex-specific pain differences SD Linnstaedt, MG Walker, JS Parker, E Yeh, RL Sons, E Zimny, ... Molecular pain 11, s12990-015-0069-3, 2015 | 37 | 2015 |
| Telmisartan therapy does not improve lymph node or adipose tissue fibrosis more than continued antiretroviral therapy alone NS Utay, DW Kitch, E Yeh, CJ Fichtenbaum, MM Lederman, JD Estes, ... The Journal of infectious diseases 217 (11), 1770-1781, 2018 | 26 | 2018 |
| Recurrence of symptoms following a 2-day symptom free period in patients with COVID-19 DM Smith, JZ Li, C Moser, E Yeh, JS Currier, KW Chew, MD Hughes, ... JAMA Network Open 5 (10), e2238867-e2238867, 2022 | 16 | 2022 |
| Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate: AIDS Clinical Trials Group Study A5314 JH Stein, E Yeh, JM Weber, C Korcarz, PM Ridker, A Tawakol, PY Hsue, ... Arteriosclerosis, thrombosis, and vascular biology 38 (12), 2870-2878, 2018 | 16 | 2018 |
| Assessing the probiotic effect in treated HIV: results of ACTG A5350 ET Overton, E Yeh, R Presti, J Jacobson, B Williams, C Wilson, A Landay, ... Conference on retroviruses and opportunistic infections (CROI), 2019 | 9 | 2019 |
| A randomized, placebo-controlled trial assessing the effect of VISBIOME ES probiotic in people with HIV on antiretroviral therapy RM Presti, E Yeh, B Williams, A Landay, JM Jacobson, C Wilson, ... Open Forum Infectious Diseases 8 (12), ofab550, 2021 | 8 | 2021 |
| Bone mineral density reductions after tenofovir disoproxil fumarate initiation and changes in phosphaturia: a secondary analysis of ACTG A5224s SK Gupta, E Yeh, DW Kitch, TT Brown, CS Venuto, GD Morse, B Ha, ... Journal of Antimicrobial Chemotherapy 72 (7), 2042-2048, 2017 | 6 | 2017 |
| Assessing the probiotic effect in treated HIV: results of ACTG A5350. Abstract# 35 ET Overton, E Yeh, R Presti Conference on Retroviruses and Opportunistic Infections Seattle, USA, 2019 | 5 | 2019 |
| Effects of probiotic Visbiome ES on colonic mucosal CD4 cells: results from A5352S R Presti, DW Kitch, A Andrade, A Landay, J Jacobson, C Wilson, E Yeh, ... Conference on Retroviruses and Opportunistic Infections (CROI), 2018 | 5 | 2018 |
| A5317 AIDS Clinical Trials Group Team. Telmisartan therapy does not improve lymph node or adipose tissue fibrosis more than continued antiretroviral therapy alone NS Utay, DW Kitch, E Yeh, CJ Fichtenbaum, MM Lederman, JD Estes J Infect Dis 217 (11), 1770-1781, 2018 | 5 | 2018 |
| Symptom outcome measures for outpatient COVID-19 phase 3 treatment trials KW Chew, CB Moser, ES Daar, DA Wohl, E Yeh, J Ritz, AC Javan, ... Topics in Antiviral Medicine, 140-141, 2021 | 4 | 2021 |
| Methotrexate inhibits T cell proliferation but not inflammatory cytokine expression to modulate immunity in people living with HIV ML Freeman, BM Clagett, D Moisi, E Yeh, CD Morris, A Ryu, B Rodriguez, ... Frontiers in Immunology 13, 924718, 2022 | 3 | 2022 |
| POST-ACUTE SEQUELAE of SARS-CoV-2 in NONHOSPITALIZED ACTIV-2 TRIAL PARTICIPANTS TH Evering, B Sanusi, N Jilg, E Yeh, CB Moser, DA Wohl, ES Daar, ... Topics in Antiviral Medicine, 246-246, 2022 | 2 | 2022 |
| Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial KW Chew, C Moser, E Yeh, DA Wohl, ES Daar, J Ritz, AC Javan, JJ Eron, ... The Journal of Infectious Diseases 228 (Supplement_2), S83-S91, 2023 | | 2023 |
| Long COVID After Bamlanivimab Treatment TH Evering, CB Moser, N Jilg, E Yeh, B Sanusi, DA Wohl, ES Daar, JZ Li, ... The Journal of Infectious Diseases 228 (Supplement_2), S126-S135, 2023 | | 2023 |
| Prevalence and characteristics of post-acute sequelae of SARS-CoV-2 (PASC) in non-hospitalized persons with COVID-19 enrolled in a clinical trial of early treatment (ACTIV-2) TH Evering, B Sanusi, N Jilg, E Yeh, C Moser, J Ritz, D Wohl, ES Daar, ... Antiviral Therapy, 8-8, 2021 | | 2021 |
| Effects of Low-Dose Methotrexate on Brachial Artery Echogenicity and Grayscale Texture in HIV-Infected Individuals at Increased Cardiovascular Disease Risk: AIDS Clinical … JH Stein, E Yeh, JM Weber, CE Korcarz, PM Ridker, A Tawakol, PY Hsue, ... Circulation 138 (Suppl_1), A10607-A10607, 2018 | | 2018 |
| Bone Mineral Density (BMD) Reductions After Tenofovir Disoproxil Fumarate (TDF) Initiation Are Not Associated With Changes in Phosphaturia: A Secondary Analysis of ACTG A5224s S Gupta, E Yeh, D Kitch, T Brown, C Venuto, G Morse, B Ha, K Melbourne, ... Open Forum Infectious Diseases 3 (suppl_1), 2188, 2016 | | 2016 |
